154 related articles for article (PubMed ID: 2413480)
41. HbF synthesis during stress erythropoiesis as determined by gamma-mRNA/non-alpha-mRNA quantification.
Bard H; Gagnon C; Peri KG
Pediatr Res; 1999 May; 45(5 Pt 1):684-6. PubMed ID: 10231865
[TBL] [Abstract][Full Text] [Related]
42. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.
Charache S; Dover G; Smith K; Talbot CC; Moyer M; Boyer S
Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4842-6. PubMed ID: 6192443
[TBL] [Abstract][Full Text] [Related]
43. Approaches to the reactivation of hemoglobin F as a treatment for sickle cell disease.
DeSimone J
Clin Adv Hematol Oncol; 2004 Jan; 2(1):23-4. PubMed ID: 16163154
[No Abstract] [Full Text] [Related]
44. Hydroxyurea treatment for sickle cell disease.
Steinberg MH
ScientificWorldJournal; 2002 Jun; 2():1706-28. PubMed ID: 12806165
[TBL] [Abstract][Full Text] [Related]
45. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia.
Fibach E; Prasanna P; Rodgers GP; Samid D
Blood; 1993 Oct; 82(7):2203-9. PubMed ID: 7691251
[TBL] [Abstract][Full Text] [Related]
46. Influence of hydroxyurea on fetal hemoglobin production in vitro.
Miller BA; Platt O; Hope S; Dover G; Nathan DG
Blood; 1987 Dec; 70(6):1824-9. PubMed ID: 2445401
[TBL] [Abstract][Full Text] [Related]
47. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells.
Moutouh-de Parseval LA; Verhelle D; Glezer E; Jensen-Pergakes K; Ferguson GD; Corral LG; Morris CL; Muller G; Brady H; Chan K
J Clin Invest; 2008 Jan; 118(1):248-58. PubMed ID: 18064299
[TBL] [Abstract][Full Text] [Related]
48. A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger.
Mabaera R; West RJ; Conine SJ; Macari ER; Boyd CD; Engman CA; Lowrey CH
Exp Hematol; 2008 Sep; 36(9):1057-72. PubMed ID: 18718415
[TBL] [Abstract][Full Text] [Related]
49. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia.
Charache S; Dover GJ; Moore RD; Eckert S; Ballas SK; Koshy M; Milner PF; Orringer EP; Phillips G; Platt OS
Blood; 1992 May; 79(10):2555-65. PubMed ID: 1375104
[TBL] [Abstract][Full Text] [Related]
50. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.
Atweh GF; Schechter AN
Curr Opin Hematol; 2001 Mar; 8(2):123-30. PubMed ID: 11224687
[TBL] [Abstract][Full Text] [Related]
51. Reactivation of fetal hemoglobin in adult stem cell erythropoiesis by transforming growth factor-beta.
Böhmer RM
J Hematother Stem Cell Res; 2003 Oct; 12(5):499-504. PubMed ID: 14594506
[TBL] [Abstract][Full Text] [Related]
52. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea.
Steinberg MH; Lu ZH; Barton FB; Terrin ML; Charache S; Dover GJ
Blood; 1997 Feb; 89(3):1078-88. PubMed ID: 9028341
[TBL] [Abstract][Full Text] [Related]
53. 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
Humphries RK; Dover G; Young NS; Moore JG; Charache S; Ley T; Nienhuis AW
J Clin Invest; 1985 Feb; 75(2):547-57. PubMed ID: 2579100
[TBL] [Abstract][Full Text] [Related]
54. Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease.
Saunthararajah Y; Hillery CA; Lavelle D; Molokie R; Dorn L; Bressler L; Gavazova S; Chen YH; Hoffman R; DeSimone J
Blood; 2003 Dec; 102(12):3865-70. PubMed ID: 12907443
[TBL] [Abstract][Full Text] [Related]
55. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
J Clin Invest; 1984 Aug; 74(2):652-6. PubMed ID: 6205021
[TBL] [Abstract][Full Text] [Related]
56. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
Platt OS
Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231
[TBL] [Abstract][Full Text] [Related]
57. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model.
Rivers A; Vaitkus K; Ruiz MA; Ibanez V; Jagadeeswaran R; Kouznetsova T; DeSimone J; Lavelle D
Exp Hematol; 2015 Jul; 43(7):546-53.e1-3. PubMed ID: 25931013
[TBL] [Abstract][Full Text] [Related]
58. Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness.
Zhu X; Hu T; Ho MH; Wang Y; Yu M; Patel N; Pi W; Choi JH; Xu H; Ganapathy V; Kutlar F; Kutlar A; Tuan D
Haematologica; 2017 Dec; 102(12):1995-2004. PubMed ID: 28971909
[TBL] [Abstract][Full Text] [Related]
59. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
Dover GJ; Charache S; Nora R; Boyer SH
Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
[No Abstract] [Full Text] [Related]
60. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
Krishnamoorthy S; Pace B; Gupta D; Sturtevant S; Li B; Makala L; Brittain J; Moore N; Vieira BF; Thullen T; Stone I; Li H; Hobbs WE; Light DR
JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
